ISPOR - Resource Utilization and Costs of Resected Pancreatic Cancer Patients Receiving Neoadjuvant Treatment- Findings from a Real-World U.S. Population

Full Text

Resource Utilization and Costs of Resected Pancreatic Cancer Patients Receiving Neoadjuvant Treatment- Findings from a Real-World U.S. Population

Abstract

Authors

J Kish BA Feinberg C Biggs U Mujumdar D Chopra J Laney G Kennedy

Back to Volume 19, Issue 7

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now